ArticleJournal of family medicine and primary care2026
Awareness of medication-overuse headache in Hail, Saudi Arabia.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medication-overuse headache is a common neurological disorder that results in enormous disability and suffering, typically caused by the overuse of certain medications to relieve primary headaches. It plays a significant role in the transformation of acute headache disorders to chronic headache disorders. Objective: To evaluate the level of awareness of medication-overuse headache among residents in Hail, Saudi Arabia. Methods: This cross-sectional study was conducted among 380 participants in Hail, Saudi Arabia, to evaluate the level of awareness of medication-overuse headache. An online survey was distributed to participants to participate in the study. Informed consent was obtained from the participants before participating in the study. Results: Among 380 participants, about 70% had good awareness of medication-overuse headache. In addition, 30% reported primary headaches, 48% migraine, and 40% tension type. Nearly half experienced headaches fewer than 4 days per month, while about 40% experienced headaches for 15 to 30 days per month. Paracetamol was used by 79%, while 17% used preventive medications. Conclusion: Despite high awareness about medication-overuse headache, it remains a significant issue due to frequent use of acute pain medications and limited use of preventive treatments. Health campaigns are vital to further improve awareness, reinforce safe medication practices, and promote preventive measures to reduce the prevalence and impact of medication-overuse headache.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.